eLife 3. Juni 2026 HSD17B7 is required for the function of sensory hair cells by regulating cholesterol synthesis
Merck & Co. 2. Juni 2026 Merck & Co., Inc. (MRK) Presents at American Society of Clinical Oncology (ASCO) Annual Meeting 2026 - Slideshow - Seeking Alpha
Recursion 2. Juni 2026 Recursion vs. Schrodinger: Comparing Biotech and Software Drug Discovery Strategies in 2026 - News and Statistics - IndexBox
BioPharma Dive 2. Juni 2026 Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
Clinical OMICs 2. Juni 2026 Mature Intestinal Cells Revert to Stem-Like State to Sustain Colorectal Cancer
Recursion 2. Juni 2026 A Look At Recursion Pharmaceuticals (RXRX) Valuation As Shares Show Short Term Momentum - simplywall.st
FierceBiotech 2. Juni 2026 Foundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo
FierceBiotech 2. Juni 2026 New heights for NewLimit as anti-aging biotech nabs $435M to rejuvenate old cells
Endpoints News 2. Juni 2026 FDA details flexibilities for new cell and gene therapies to leverage past data
FierceBiotech 2. Juni 2026 ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer
GE HealthCare 2. Juni 2026 GE HealthCare to Showcase Latest Technologies, AI-enabled Workflows - Imaging Technology News
Roche Media 2. Juni 2026 ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer - Fierce Biotech
Harvard Bioscience 2. Juni 2026 Harvard Bioscience stock (US4169061052): Nasdaq-listed share extends early-June rebound - AD HOC NEWS
BioPharma Dive 2. Juni 2026 Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug